Newsletter
We 💜Events, Drugs 💊 Rarebase & NOSpharma, Data 👩🏾‍💻 Simons & Invitae #S10e75

SYNGAP10

We 💜Events, Drugs 💊 Rarebase & NOSpharma, Data 👩🏾‍💻 Simons & Invitae #S10e75

GLOBAL GENES WAS GREAT Panel was impressive, will be sharing when recording is live, one point was small molecules…#GlobalGenes #CareAboutRareEVENTS ARE COMING 3 weeks! October 8 in NJ - Caren…
September 18, 2022

We 💜Events, Drugs 💊 Rarebase & NOSpharma, Data 👩🏾‍💻 Simons & Invitae #S10e75

GLOBAL GENES WAS GREAT

Panel was impressive, will be sharing when recording is live, one point was small molecules…
#GlobalGenes #CareAboutRare

EVENTS ARE COMING

3 weeks!
October 8 in NJ – Caren Leib Gala https://www.syngapresearchfund.org/get-involved/fundraising/caren-leib-gala October 8 in SC – Scramble for SYNGAP https://www.syngapresearchfund.org/get-involved/fundraising/scramble-for-syngap

8 weeks!
November 12 in GA – Sparks of Hope Gala https://syngap.fund/soiree

11 weeks!
December 1 in TN – Syngap Science Meeting – https://syngap.fund/treat

RAREBASE

Talked about this in #s10e27 https://youtu.be/r3bS9YepQ4s

We are investing in small molecule repurposing as fast as we can.  Four lines…

Cannonball 2.0 is on!  Checkout UFDtech on 21 October 2022!

LINK#UFDtech #CannonballForTheCure #RareBase

NOSPHARMA

Talked about Bowie in #s10e69 https://www.youtube.com/watch?v=xl_r4hoDlf8

Nospharma leverages unique biological causes of brain disorders within the context of what is already known, to deliver effective treatments. By placing biology-first, we’ve created new drugs and repurposed on-the-market drugs to improve treatment success.  We aim to deliver the most effective therapeutics for some of the most severe brain disorders, as quickly as possible.
…from https://www.linkedin.com/company/nospharma/
#NOSpharma 

SIMONS/INVITAE PARTNERSHIP

Two of the most important players in the Rare Epilepsy Ecosystem are partnering and it’s great news for SYNGAP1 and SRF.
https://www.prnewswire.com/news-releases/invitae-and-simons-searchlight-partner-to-accelerate-research-through-data-sharing-301621469.html
Tweet: https://twitter.com/cureSYNGAP1/status/1569326298790789122
#SimonsFoundation #Autism #Invitae #ciitizen

Satterstrom paper associates SYNGAP1 with Autism strongly
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250485/
See figure 2B https://pubmed.ncbi.nlm.nih.gov/31981491/#&gid=article-figures&pid=figure-2-uid-1

AUTISM BRAIN NETWORK

Webinar: https://www.syngapresearchfund.org/webinars/an-introduction-to-autism-brainnet Site: https://www.autismbrainnet.org/ 

etc.

This is a podcast: subscribe to and rate this 10 minute #podcast #SYNGAP10 here https://www.syngapresearchfund.org/syngap10-podcast 

Apple podcasts: https://syngap.fund/10a

 

Episode 75 of Syngap10 – September 18, 2022 

 

#Syngap #SYNGAP1 #epilepsy #autism #intellectualdisability #id #anxiety #raredisease #epilepsyawareness #autismawareness #rarediseaseresearch #SynGAPResearchFund #CareAboutRare #PatientAdvocacy #GCchat #Neurology

You may also like

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

Buffer LinkedIn WhatsApp